Concepedia

Venugopal Gunda

VG

21

Publications

2.4K

Citations

17

H-Index

2013

Active since

Affiliations

University of Nebraska Medical Center(Current)

University of Nebraska–Lincoln

Translational Genomics Research Institute

Texas A&M Health Science Center

George Mason University

Venugopal Gunda is an author at University of Nebraska Medical Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2024

21

Publications

21

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 695 citations

, , +9

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

Surendra K. Shukla, Vinee Purohit, Kamiya Mehla et al. · Cancer Cell · 2017 · 531 citations · Full text

, , +7

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia

Surendra K. Shukla, Teklab Gebregiworgis, Vinee Purohit et al. · Cancer & Metabolism · 2014 · 246 citations · Full text

<i>De Novo</i> Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer

Saber Tadros, Surendra K. Shukla, Ryan J. King et al. · Cancer Research · 2017 · 222 citations · Full text

MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer

Venugopal Gunda, Joshua J. Souchek, Jaime Abrego et al. · Clinical Cancer Research · 2017 · 97 citations · Full text

Rows per page

1–5 of 21